GABAa5 modulator program (Saniona)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGABAa5 modulator program (Saniona)
Drug Alias NameCNS program (Aniona/Janssen)GABAa5 modulator program (Saniona/Janssen)CNS program (Saniona/Janssen)AN-470
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-5 modulators
TargetsGamma-aminobutyric acid A receptor alpha-5
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSaniona A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceuticals IncSaniona A/S
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A